Evidence map›Paper›PMID 38737222›Full record

ArticleThe Pan African medical journal2024

Tackling the non-communicable disease epidemic: a framework for policy action in low- and middle-income countries.

Mark Fordjour Owusu, Joseph Adu, Sebastian Gyamfi, Ebenezer Martin-Yeboah, Benjamin Ansah Dortey

Abstract read
In one paragraph

Article in The Pan African medical journal, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Mark Fordjour OwusuHigher Education Development Center, University of Otago, Christchurch Central City, Christchurch 8011, New Zealand.
Joseph AduDepartment of Health and Rehabilitation Sciences, Western University, Ontario, Canada.
Sebastian GyamfiFaculty of Nursing, University of Windsor, Windsor, Ontario, Canada.
Ebenezer Martin-YeboahDepartment of Health Information Science, Western University, London, Ontario, Canada.
Benjamin Ansah DorteyTrauma and Specialist Hospital, Winneba, Ghana.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Health policy frameworks for the prevention and control of non-communicable diseases have largely been developed for application in high-income countries. Limited attention has been given to the policy exigencies in lower- and middle-income countries where the impacts of these conditions have been most severe, and further clarification of the policy requirements for effective prevention is needed. This paper presents a policy approach to prevention that, although relevant to high-income countries, recognizes the peculiar situation of low-and middle-income countries. Rather than a narrow emphasis on the implementation of piecemeal interventions, this paper encourages policymakers to utilize a framework of four embedded policy levels, namely health services, risk factors, environmental, and global policies. For a better understanding of the non-communicable disease challenge from a policy standpoint, it is proposed that a policy framework that recognizes responsible health services, addresses key risk factors, tackles underlying health determinants, and implements global non-communicable disease conventions, offers the best leverage for prevention.

Indexed as

Developing CountriesHealth PolicyNoncommunicable DiseasesDelivery of Health CareEpidemicsGlobal HealthHealth ServicesHumansPolicy MakingRisk FactorscontrolHealth policy frameworkshigh-income countrieslower-income countriesmiddle-income countriesnon-communicable diseaseprevention

Identifiers

PMID38737222
PMCPMC11087287

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.